Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused tricyclic heterocyclic compounds as HIV integrase inhibitors

Fused tricyclic heterocyclic compounds as HIV integrase inhibitors

US Patent 9643982 · Granted May 9, 2017

Estimated economic value: $96,276,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted-isoxazoline-containing aromatic compound, preparation method therefo2025
4-pyridinyl formamide compound or derivative thereof, preparation method therefo2025
Bicyclic heterocycle compounds methods of use thereof for the treatment of herpe2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Substituted thiadiazinone dioxide and preparation method therefor, herbicidal co2025
Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor2025
Anti-influenza virus pyrimidine derivatives2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025